The ideal solution for your Drugs of Abuse screening

Randox have developed an innovative multi-marker Drugs of Abuse testing procedure for rapid drug screening programmes. Randox DoA Arrays require very little sample volume thus enabling more analytes to be tested using less resources. Our DoA arrays show excellent correlation with GCMS, therefore providing confidence in results and an ideal solution for drug screening programmes.

Benefits

• Dedicated kits for different sample types – urine, whole blood and oral fluid.
• Whole blood kits eliminate the need for lengthy extraction procedures.
• Two test sites for Benzodiazepines on DoA I allows discrimination of Oxazepam and Lorazepam with cross reactivities for other benzodiazepines.
• Different test sites for oxycodone and other opioids on DoA II to increase potential information from the screening tests.